GINA RISALITI: Open Payments
NPI 1730595083 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 77 payments from 21 companies in 2025. Trend: 2023 $1,493 · 2024 $1,649 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $223 |
| ABBVIE INC. | 12 | $215 |
| PFIZER INC. | 9 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Lilly USA, LLC | 5 | $75 |
| Exact Sciences Corporation | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| Axsome Therapeutics, Inc. | 2 | $35 |
Products named: UBRELVY, Ozempic, REXULTI, JARDIANCE, Rybelsus, PREVNAR 20, Kerendia, The Cologuard Plus Collection Kit.
Industry payments across OH — which companies pay providers there.
